Management of patients with malignant and benign bone tumors. 10 Years experience of Kazakh scientific research institute of oncology and radiology
- Authors: Serikbayev G.A.1, Maulenov Z.O.1, Tuleuova D.A.1, Kurmanaliyev A.K.1, Akhmetova G.S.1
-
Affiliations:
- Kazakh scientific research institute of oncology and radiology
- Issue: Vol 7, No 4 (2015)
- Pages: 36-41
- Section: BONE SARCOMAS
- Published: 22.11.2015
- URL: https://sarbon.abvpress.ru/jour/article/view/396
- ID: 396
Cite item
Full Text
Abstract
Primary bones tumors make 0,2–1% of all oncological diseases (1,2–1,9 cases on 100 000 population). In dynamics for the past10 years according to statistical data of Republic Kazakhstan incidence is stable, mortality is decreasing, and 5-year survival increased for 10%.
Since 2012 Center of tumors of bones, soft tissue and melanomas was established. From 2005 till 2014 772 patients with primary tumors of bones and soft tissues and also metastatic bone involvement were treated.
Keywords
About the authors
G. A. Serikbayev
Kazakh scientific research institute of oncology and radiology
Author for correspondence.
Email: ganiserikbaev@mail.ru
Almaty
KazakhstanZh. O. Maulenov
Kazakh scientific research institute of oncology and radiology
Almaty
KazakhstanD. A. Tuleuova
Kazakh scientific research institute of oncology and radiology
Almaty
KazakhstanA. K. Kurmanaliyev
Kazakh scientific research institute of oncology and radiology
Almaty
KazakhstanG. S. Akhmetova
Kazakh scientific research institute of oncology and radiology
Almaty
KazakhstanReferences
Supplementary files


